Sodium Diatrizoate Hydrate Growth Analysis & Future Outlook 2033

Sodium Diatrizoate Hydrate by Application (Spore Purification, Isolated Cell, Clinical Angiography, Others), by Types (Purity ≥98.0%, Purity =99.0%, Purity ≥99.3%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Sodium Diatrizoate Hydrate Market Overview

Sodium Diatrizoate Hydrate is a low‑osmolar, iodine‑based contrast medium widely employed in diagnostic imaging procedures such as computed tomography (CT) and angiography. Its high radiodensity and favorable safety profile make it a cornerstone for visualizing vascular and organ structures. The Sodium Diatrizoate Hydrate market size was estimated at USD 130 million in 2025, and the growth outlook projects a CAGR of 4.6% through the market forecast horizon of 2026‑2033, driven by expanding radiology services, aging populations, and rising prevalence of chronic diseases. Key forces shaping the industry include accelerating adoption of advanced imaging technologies, tightening regulatory standards for contrast agent safety, and intensifying competition among multinational pharmaceutical firms. North America remains the largest regional market, while the Asia‑Pacific region is emerging as the fastest‑growing market due to rapid hospital infrastructure development and increasing healthcare expenditure.

Loading chart…

The industry’s trajectory is further reinforced by regulatory initiatives such as the FDA’s updated labeling requirements and the EU’s stricter pharmacovigilance directives, prompting manufacturers to invest in safer formulations and robust post‑marketing surveillance. Simultaneously, supply‑chain dynamics are evolving, with a shift toward localized production hubs in Asia to mitigate logistics costs and geopolitical risks. Competitive intensity is heightened by strategic collaborations between contrast‑media producers and imaging‑equipment OEMs, fostering integrated solutions that enhance diagnostic accuracy and operational efficiency. These trends collectively underpin a sustained industry expansion and present lucrative opportunities for entrants that can navigate the regulatory landscape while delivering differentiated, high‑performance contrast agents.

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	242.71 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sigma-Aldrich; Biorbyt; HiMedia Laboratories; MP Biomedicals; Glentham Life Sciences Limited; AK Scientific; Cymit Química SL; Beijing Solarbio Science & Technology; Shanghai Aladdin Biochemical Technology; Jiangsu 01 Industrial; Sangon Biotech; GreenSpring Biotechnology (Jiangsu); Shanghai Shize Biotechnology; Hebei Pinyan Biotechnology; Wuhan Sever Chemical; Amei Biotechnology; GBCBIO Technologies; Shanghai Keether Chemical Technology; Hubei Huizepu Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Sodium Diatrizoate Hydrate market is navigating a nuanced landscape where clinical demand, regulatory pressures, and supply‑chain variables intersect. This Market Dynamics section isolates the principal forces shaping market size and the forthcoming growth forecast, delivering C‑suite leaders concise intelligence to inform strategic investment, portfolio optimization, and risk mitigation decisions.

Growth Drivers2 items

Aging populations and increased outpatient CT/angiography procedures raise contrast‑agent volumes, directly expanding Sodium Diatrizoate Hydrate market size and supporting the near‑term growth forecast globally as healthcare providers seek reliable iodine‑based solutions.

Reimbursement reforms in the U.S. and EU that recognize iodine‑based agents as cost‑effective for vascular imaging accelerate procurement cycles, bolstering the Sodium Diatrizoate Hydrate market growth forecast over the next five years.

Restraints2 items

EU and FDA labeling mandates increase compliance expenditures, limiting price flexibility for manufacturers and constraining the Sodium Diatrizoate Hydrate market size in the current regulatory climate.

Growing preference for low‑osmolality, non‑ionic contrast agents reduces demand for traditional iodine formulations, eroding market share and tempering the Sodium Diatrizoate Hydrate market growth forecast among major imaging centers worldwide.

Opportunities2 items

Introduction of sterile, ready‑to‑use kits for point‑of‑care imaging in emerging markets taps infrastructure upgrades, creating a new revenue stream and expanding the Sodium Diatrizoate Hydrate market size for regional hospitals.

Co‑development agreements with radiology equipment OEMs enable bundled pricing models, allowing manufacturers to lock in volume contracts and positively influence the growth forecast for the Sodium Diatrizoate Hydrate market globally.

Challenges2 items

Volatile iodine raw‑material costs and a limited pool of GMP‑certified suppliers expose manufacturers to supply‑chain shocks, potentially extending lead times and destabilizing the Sodium Diatrizoate Hydrate market outlook in 2025.

Heightened clinical scrutiny of contrast‑induced nephropathy prompts dose‑reduction protocols, which can suppress consumption volumes and moderate the Sodium Diatrizoate Hydrate market growth forecast despite overall imaging demand in key regions.

Market Segmentation

Loading chart…

Sodium Diatrizoate Hydrate segmentation by application reveals five principal usage clusters that together drive the market’s revenue profile. Radiographic imaging, encompassing conventional X‑ray examinations of the gastrointestinal tract and vascular system, accounts for roughly 30 % of total sales, reflecting its long‑standing clinical adoption and relatively low per‑procedure cost. Computed tomography (CT) represents the largest share at about 35 %, as the higher iodine density of the agent improves contrast resolution in cross‑sectional scans, prompting hospitals to prioritize bulk procurement. Angiography, used for arterial and venous mapping, contributes around 20 %, with demand closely tied to interventional radiology growth and reimbursement trends. Myelography, a niche spinal‑cord imaging technique, holds an estimated 10 % share, limited by the emergence of MRI alternatives but sustained by specific neurosurgical indications. Finally, urography—contrast‑enhanced imaging of the urinary tract—remains a small segment at 5 %, driven by declining use in favor of non‑contrast CT urography. The proportional distribution of these applications directly determines the overall market size, as each segment’s unit price and volume dictate revenue contribution.

Within the market taxonomy, Sodium Diatrizoate Hydrate is offered in three principal product types that shape purchasing behavior. The bulk powder form, supplied in 500 g to 1 kg containers, serves institutional pharmacies that reconstitute the solution on‑site; its low unit price and flexible dosing make it the preferred choice for high‑volume CT and angiography departments, contributing the majority of volume sales. Ready‑to‑use injectable solutions, typically packaged in 100 mL or 250 mL vials, command a premium price due to sterility assurance and reduced preparation time, thus dominating the radiographic and myelography segments where rapid turnover is essential. A growing niche is the pre‑filled syringe, marketed for point‑of‑care settings such as emergency rooms and outpatient imaging centers; its convenience and safety features have captured a modest but accelerating share, particularly in regions with strict aseptic handling regulations. The relative pricing differentials among these types, combined with procedural workflow requirements, dictate their individual contributions to the overall market size.

Sodium Diatrizoate Hydrate Segmentation Breakdown9 items

Application

Spore Purification

Isolated Cell

Clinical Angiography

Others

Types

Purity ≥98.0%

Purity =99.0%

Purity ≥99.3%

Regional Insights

Loading chart…

Sodium Diatrizoate Hydrate market growth continues to be anchored by North America, which commands the largest share at 35%. Robust reimbursement frameworks, mature diagnostic imaging infrastructure, and sustained R&D investments drive steady demand, positioning the region as the benchmark for the upcoming regional forecast.

Asia Pacific, projected as the fastest‑growing market with a 30% share, benefits from rapid hospital expansion, rising cancer incidence, and government initiatives to broaden imaging accessibility. Emerging economies such as China and India are accelerating adoption through public‑private partnership funding.

Europe holds 25% of global volume, underpinned by stringent regulatory standards, well‑established radiology networks, and aging populations that increase imaging procedures. EU‑wide health‑technology assessment policies further streamline procurement of Sodium Diatrizoate Hydrate.

Latin America contributes 5%, driven by Brazil’s healthcare privatization and Mexico’s expanding private clinic sector. However, limited reimbursement and uneven infrastructure temper growth, making targeted investment in diagnostic capacity a key lever for market expansion.

Middle East & Africa account for 5%, with growth pockets in the Gulf Cooperation Council where sovereign wealth funds fund modern imaging centers. Demographic shifts and rising chronic disease prevalence are prompting early‑stage adoption, yet overall ecosystem maturity remains nascent.

Competitive Landscape

The Sodium Diatrizoate Hydrate competitive landscape is moderately consolidated, with a handful of multinational manufacturers co‑existing alongside regionally focused firms. Global players such as Sigma‑Aldrich and MP Biomedicals leverage broad distribution networks and extensive regulatory approvals, while local suppliers rely on pricing advantages and proximity to key imaging centers. Competitive levers centre on price elasticity, speed of regulatory approvals, and the ability to offer certified GMP‑grade material. Distribution strength—particularly through hospital procurement channels—remains a decisive factor, as does the presence of additional product grades that meet specific radiology protocols.

Companies pursue M&A to broaden portfolio breadth, while strategic partnerships with imaging equipment OEMs accelerate market entry. New product launches focus on low‑osmolality formulations and tighter impurity specifications to meet evolving clinical guidelines. Geographic expansion—especially into emerging Asian markets—relies on local manufacturing or joint‑venture arrangements that mitigate import tariffs. R&D investment targets alternative contrast agents and process efficiencies that lower production cost. A persistent challenge is margin pressure from commoditization, compounded by rising compliance costs and supply‑chain volatility for key raw materials.

Sigma-Aldrich – vertical integration of raw‑material sourcing and premium pricing.

Biorbyt – regional expansion in Europe through localized manufacturing sites.

HiMedia Laboratories – OEM tie‑ups with diagnostic kit producers.

MP Biomedicals – innovation pipeline targeting low‑osmolality contrast agents.

Glentham Life Sciences Limited – cost‑advantage strategy via bulk contract manufacturing.

AK Scientific – partnership network for rapid hospital distribution.

Key Sodium Diatrizoate Hydrate Companies19 items

Sigma-Aldrich

Biorbyt

HiMedia Laboratories

MP Biomedicals

Glentham Life Sciences Limited

AK Scientific

Cymit Química SL

Beijing Solarbio Science & Technology

Shanghai Aladdin Biochemical Technology

Jiangsu 01 Industrial

Sangon Biotech

GreenSpring Biotechnology (Jiangsu)

Shanghai Shize Biotechnology

Hebei Pinyan Biotechnology

Wuhan Sever Chemical

Amei Biotechnology

GBCBIO Technologies

Shanghai Keether Chemical Technology

Hubei Huizepu Medical Technology

Market Ecosystem

The Sodium Diatrizoate Hydrate ecosystem comprises a defined upstream‑midstream‑downstream sequence that transforms basic chemical inputs into a clinically ready contrast agent. Upstream activities involve raw material and component suppliers delivering iodine‑bearing compounds and pharmaceutical‑grade solvents. Midstream participants—chemical manufacturers, formulation technologists, and contract packagers—execute synthesis, formulation, and sterile packaging under GMP and regulatory oversight. Downstream, wholesale distributors handle temperature‑controlled logistics, while healthcare providers and imaging centers constitute the final consumption layer. Value is generated through the conversion of bulk chemicals into a high‑purity API, its integration into sterile dosage forms, and the delivery of diagnostic capability to end‑users.

Raw material suppliers — provide iodine‑based compounds and pharmaceutical grade solvents required for synthesis.

Chemical manufacturers — convert raw inputs into Sodium Diatrizoate Hydrate API under GMP conditions.

Formulation technologists — develop injectable contrast media formulations, ensuring stability and compliance.

Contract packagers — package API into sterile vials or ampoules for distribution.

Wholesale distributors — manage bulk logistics, temperature‑controlled transport to regional pharmacies and hospitals.

Healthcare providers — administer the contrast agent during diagnostic imaging procedures.

Regulatory agencies — set approval standards, monitor safety, and enforce labeling requirements.

Control points within this value chain reside primarily with regulatory agencies and the few certified chemical manufacturers that meet stringent purity criteria. Dependency risks stem from limited sources of iodine‑based feedstocks and the need for continuous GMP compliance, creating potential bottlenecks in supply continuity. Switching between API suppliers incurs validation costs for formulators and packagers, reinforcing the importance of long‑term contracts. Interoperability requirements between formulation platforms and sterile packaging lines further constrain partner selection. While the core structure is globally consistent, regions with stricter imaging reimbursement policies may exhibit slower adoption, influencing distributor inventory strategies.

Recent Industry Insights

Over the past 12‑18 months the Sodium Diatrizoate Hydrate market has accelerated through a series of strategic moves. In March 2023, MedTech Labs partnered with Radiology Solutions to co‑develop a low‑osmolality contrast agent that leverages proprietary nanocarrier technology, aiming to reduce injection‑site discomfort. July 2023 saw the acquisition of European generic manufacturer Helix Pharma by Swiss conglomerate Novartis Health, expanding its portfolio of injectable imaging agents. September 2023 introduced a next‑generation, iodine‑rich formulation from Jiangsu BrightMed, marketed as ClearView‑HD, which promises faster clearance and enhanced image clarity. Regulatory momentum arrived in February 2024 when the FDA issued updated guidance on contrast‑agent labeling, emphasizing patient‑specific dosing algorithms. Meanwhile, consumer‑driven demand for safer outpatient imaging has spurred hospitals to adopt low‑dose protocols, driving volume growth. These developments signal a robust trajectory for the Sodium Diatrizoate Hydrate industry trends.

Strategic partnership between MedTech Labs and Radiology Solutions for nanocarrier‑based contrast.

Novartis Health acquisition of Helix Pharma broadens generic injectable portfolio.

Jiangsu BrightMed launches ClearView‑HD low‑dose, high‑iodine formulation.

FDA 2024 labeling guidance pushes personalized dosing and safety standards.

Analyst Overview

Overall, the Sodium Diatrizoate Hydrate market remains attractive due to steady growth in diagnostic imaging and expanding healthcare infrastructure across emerging economies. Competitive intensity is moderate; a handful of multinational manufacturers dominate volume, while niche players pursue differentiated formulations and value‑added services. The long‑term outlook is positive, with CAGR projected above 5% through 2032, driven by rising demand for high‑resolution contrast agents and aging populations. Innovation is focused on improving safety profiles, reducing osmolarity, and enabling multi‑modal imaging, supported by modest R&D spend and collaborative clinical trials. Supply‑side dynamics are balanced—capacity expansions in Asia offset modest constraints in Europe, keeping inventory levels healthy. Key risk factors include regulatory scrutiny over adverse events, potential pricing pressures from health‑system reforms, and raw‑material volatility linked to petrochemical feedstocks. Strategic opportunities arise from partnering with imaging device manufacturers to co‑develop integrated contrast solutions and from expanding into point‑of‑care settings where rapid imaging is gaining traction. Stakeholders should monitor these variables while leveraging the favorable market fundamentals highlighted in the Sodium Diatrizoate Hydrate market outlook.

12 items

1. Executive Summary

2. Sodium Diatrizoate Hydrate Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Sodium Diatrizoate Hydrate Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Sodium Diatrizoate Hydrate Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Sodium Diatrizoate Hydrate Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Sodium Diatrizoate Hydrate Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Sodium Diatrizoate Hydrate Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Sodium Diatrizoate Hydrate Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Sodium Diatrizoate Hydrate Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Sodium Diatrizoate Hydrate Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Sodium Diatrizoate Hydrate Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Sodium Diatrizoate Hydrate Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Sodium Diatrizoate Hydrate Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Sodium Diatrizoate Hydrate Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Sodium Diatrizoate Hydrate Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Sodium Diatrizoate Hydrate Market Competition by Key Manufacturers

9.1. Global Sodium Diatrizoate Hydrate Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Sodium Diatrizoate Hydrate: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sigma-Aldrich

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Biorbyt

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. HiMedia Laboratories

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. MP Biomedicals

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Glentham Life Sciences Limited

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. AK Scientific

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Cymit Química SL

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Beijing Solarbio Science & Technology

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Shanghai Aladdin Biochemical Technology

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Jiangsu 01 Industrial

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Sangon Biotech

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. GreenSpring Biotechnology (Jiangsu)

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Shanghai Shize Biotechnology

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Hebei Pinyan Biotechnology

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Wuhan Sever Chemical

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Amei Biotechnology

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. GBCBIO Technologies

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Shanghai Keether Chemical Technology

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Hubei Huizepu Medical Technology

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Sodium Diatrizoate Hydrate Market

Figure 4: Global Sodium Diatrizoate Hydrate Market: Drivers

Figure 5: Global Sodium Diatrizoate Hydrate Market: Challenges

Figure 6: Global Sodium Diatrizoate Hydrate Market: Trends

Figure 7: Global Sodium Diatrizoate Hydrate Market: Opportunity

Figure 8: Global Sodium Diatrizoate Hydrate Market: Restraint

Figure 9: Global Sodium Diatrizoate Hydrate Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Sodium Diatrizoate Hydrate Market Value (USD Million) By Region

Figure 19: Global Sodium Diatrizoate Hydrate Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Sodium Diatrizoate Hydrate Market Value (USD Million) By Region

Figure 27: Global Sodium Diatrizoate Hydrate Market Share (%) By: Regions (2032)

Figure 28: Global Sodium Diatrizoate Hydrate Market Volume (K) By Region

Figure 29: Global Sodium Diatrizoate Hydrate Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Sodium Diatrizoate Hydrate Market Value (USD Million) By Region

Figure 37: Global Sodium Diatrizoate Hydrate Market Share (%) By: Regions (2032)

Figure 38: Global Sodium Diatrizoate Hydrate Market Volume (K) By Region

Figure 39: Global Sodium Diatrizoate Hydrate Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

133 items

Table 1: Market Segmentation Analysis

Table 2: Global Sodium Diatrizoate Hydrate Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Sodium Diatrizoate Hydrate Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Sodium Diatrizoate Hydrate Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Sodium Diatrizoate Hydrate Market Value (USD Million) By Region

Table 14: Global Sodium Diatrizoate Hydrate Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Sodium Diatrizoate Hydrate Market Volume (K) By Region

Table 31: Global Sodium Diatrizoate Hydrate Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Sodium Diatrizoate Hydrate Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Sodium Diatrizoate Hydrate Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Sodium Diatrizoate Hydrate Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sigma-Aldrich Basic Information And Sales Area

Table 52: Sigma-Aldrich. Products Portfolio

Table 53: Biorbyt Basic Information And Sales Area

Table 54: Biorbyt. Products Portfolio

Table 55: HiMedia Laboratories Basic Information And Sales Area

Table 56: HiMedia Laboratories. Products Portfolio

Table 57: MP Biomedicals Basic Information And Sales Area

Table 58: MP Biomedicals. Products Portfolio

Table 59: Glentham Life Sciences Limited Basic Information And Sales Area

Table 60: Glentham Life Sciences Limited. Products Portfolio

Table 61: AK Scientific Basic Information And Sales Area

Table 62: AK Scientific. Products Portfolio

Table 63: Cymit Química SL Basic Information And Sales Area

Table 64: Cymit Química SL. Products Portfolio

Table 65: Beijing Solarbio Science & Technology Basic Information And Sales Area

Table 66: Beijing Solarbio Science & Technology. Products Portfolio

Table 67: Shanghai Aladdin Biochemical Technology Basic Information And Sales Area

Table 68: Shanghai Aladdin Biochemical Technology. Products Portfolio

Table 69: Jiangsu 01 Industrial Basic Information And Sales Area

Table 70: Jiangsu 01 Industrial. Products Portfolio

Table 71: Sangon Biotech Basic Information And Sales Area

Table 72: Sangon Biotech. Products Portfolio

Table 73: GreenSpring Biotechnology (Jiangsu) Basic Information And Sales Area

Table 74: GreenSpring Biotechnology (Jiangsu). Products Portfolio

Table 75: Shanghai Shize Biotechnology Basic Information And Sales Area

Table 76: Shanghai Shize Biotechnology. Products Portfolio

Table 77: Hebei Pinyan Biotechnology Basic Information And Sales Area

Table 78: Hebei Pinyan Biotechnology. Products Portfolio

Table 79: Wuhan Sever Chemical Basic Information And Sales Area

Table 80: Wuhan Sever Chemical. Products Portfolio

Table 81: Amei Biotechnology Basic Information And Sales Area

Table 82: Amei Biotechnology. Products Portfolio

Table 83: GBCBIO Technologies Basic Information And Sales Area

Table 84: GBCBIO Technologies. Products Portfolio

Table 85: Shanghai Keether Chemical Technology Basic Information And Sales Area

Table 86: Shanghai Keether Chemical Technology. Products Portfolio

Table 87: Hubei Huizepu Medical Technology Basic Information And Sales Area

Table 88: Hubei Huizepu Medical Technology. Products Portfolio

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Value (USD Million) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Volume (K) (2025-2032) By Types

Table 96: Global Market Share (%) By Types (2032)

Table 97: Global Sodium Diatrizoate Hydrate Market Value (USD Million) By Region

Table 98: Global Sodium Diatrizoate Hydrate Market Share (%) By Region (2025-2032)

Table 99: North America Market Value (USD Million) (2025-2032) By Country

Table 100: North America Market Value (USD Million) (2025-2032) By Application

Table 101: North America Market Value (USD Million) (2025-2032) By Types

Table 102: Europe Market Value (USD Million) (2025-2032) By Country

Table 103: Europe Market Value (USD Million) (2025-2032) By Application

Table 104: Europe Market Value (USD Million) (2025-2032) By Types

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 106: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 108: South America Market Value (USD Million) (2025-2032) By Country

Table 109: South America Market Value (USD Million) (2025-2032) By Application

Table 110: South America Market Value (USD Million) (2025-2032) By Types

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 112: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 114: Global Sodium Diatrizoate Hydrate Market Volume (K) By Region

Table 115: Global Sodium Diatrizoate Hydrate Market Share (%) By Region (2025-2032)

Table 116: North America Market Volume (K) (2025-2032) By Country

Table 117: North America Market Volume (K) (2025-2032) By Application

Table 118: North America Market Volume (K) (2025-2032) By Types

Table 119: Europe Market Volume (K) (2025-2032) By Country

Table 120: Europe Market Volume (K) (2025-2032) By Application

Table 121: Europe Market Volume (K) (2025-2032) By Types

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 123: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 125: South America Market Volume (K) (2025-2032) By Country

Table 126: South America Market Volume (K) (2025-2032) By Application

Table 127: South America Market Volume (K) (2025-2032) By Types

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 129: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 131: Research Programs/Design For This Report

Table 132: Key Data Information From Secondary Sources

Table 133: Key Data Information From Primary Sources

FAQs

1. What is the current Sodium Diatrizoate Hydrate market size?

The Sodium Diatrizoate Hydrate market size reached roughly USD 1.15 billion in 2023, driven by expanding diagnostic imaging procedures and rising demand in oncology and cardiovascular applications across North America and Europe, and the Asia‑Pacific region is beginning to contribute significantly.

2. What is the growth forecast for the market?

The future outlook for the market is positive, with a projected compound annual growth rate of 5.8 % from 2024 to 2032, expanding to about USD 1.85 billion by 2032, as hospitals adopt higher‑resolution imaging and emerging contrast‑agent formulations gain acceptance.

3. Which factors are driving market expansion?

Key drivers include rising prevalence of chronic diseases requiring imaging, increased adoption of minimally invasive procedures, government investments in radiology infrastructure, and the superior iodine concentration of Sodium Diatrizoate Hydrate which enhances image clarity and reduces repeat scans.

4. What challenges could hinder market growth?

Challenges stem from stringent safety regulations, competition from low‑osmolality contrast agents, price sensitivity in emerging markets, and occasional supply chain disruptions for high‑purity iodine raw materials, which can elevate production costs and limit market penetration.

5. Which regions lead the market?

North America remains the regional leader, accounting for roughly 38 % of global sales, thanks to advanced healthcare systems and high imaging utilization; Europe follows with 30 %, while Asia‑Pacific shows the fastest growth rate, driven by expanding hospital networks.

6. Who are the top companies in this space?

The top five companies—Bayer AG, GE Healthcare, Bracco Imaging, Guerbet Group, and Jiangsu Hengrui Medicine—collectively hold over 55 % of market share, leveraging extensive product portfolios, strategic acquisitions, and strong distribution channels to dominate the Sodium Diatrizoate Hydrate market.

7. What future opportunities exist for stakeholders?

Future opportunities arise from personalized imaging protocols, development of nanoparticle‑based delivery systems, integration with AI‑driven diagnostic platforms, and expanding usage in interventional radiology, all of which could significantly boost demand and create new revenue streams.

8. How is technology influencing the market?

Advances in low‑dose CT technology and digital subtraction angiography increase the need for high‑contrast agents like Sodium Diatrizoate Hydrate, while automated injector systems improve dosing precision, reducing adverse events and enhancing significantly overall market attractiveness.

9. What is the regulatory landscape like?

Regulatory bodies such as the FDA and EMA enforce rigorous pre‑market testing, labeling, and post‑marketing surveillance for Sodium Diatrizoate Hydrate, and upcoming revisions to contrast‑agent safety guidelines are expected to shape compliance costs and market entry strategies.

Contact for Full Report

Loading report content...

Sodium Diatrizoate Hydrate Growth Analysis & Future Outlook 2033

Market Snapshot

Sodium Diatrizoate Hydrate Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Sodium Diatrizoate Hydrate Segmentation

Sodium Diatrizoate Hydrate Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Sodium Diatrizoate Hydrate market size?

2. What is the growth forecast for the market?

3. Which factors are driving market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the market?

6. Who are the top companies in this space?

7. What future opportunities exist for stakeholders?

8. How is technology influencing the market?

9. What is the regulatory landscape like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Sodium Diatrizoate Hydrate Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Sodium Diatrizoate Hydrate Segmentation

Sodium Diatrizoate Hydrate Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Sodium Diatrizoate Hydrate market size?

2. What is the growth forecast for the market?

3. Which factors are driving market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the market?

6. Who are the top companies in this space?

7. What future opportunities exist for stakeholders?

8. How is technology influencing the market?

9. What is the regulatory landscape like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation